Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers

Area of Science:

• Biomarker Discovery
• Proteomics
• Gastroenterology

Background:

• Colorectal cancer (CRC) is a leading cause of cancer mortality.
• Early CRC detection significantly improves survival rates (>90% with timely resection).
• Current diagnostic biomarkers lack the necessary sensitivity and specificity for early detection.

Purpose of the Study:

• To develop novel, non-invasive biomarkers for early colorectal cancer (CRC) detection.
• To establish robust protocols for analyzing the fecal proteome for CRC biomarkers.
• To advance the use of fecal samples for improved CRC surveillance.

Main Methods:

• Utilizing mass spectrometry for targeted discovery and validation of CRC biomarkers.
• Developing protocols to mine the fecal proteome for candidate proteins.
• Identifying proteotypic/unitypic peptides for sensitive and specific quantitative multiplexed analysis.
• Performing high-throughput analysis of clinical samples.

Main Results:

• Detailed protocols are presented for fecal proteome analysis.
• Methods enable identification of candidate proteins and specific peptides for CRC detection.
• The approach facilitates high-throughput analysis of clinical samples.

Conclusions:

• Fecal sample analysis offers advantages for non-invasive CRC biomarker discovery.
• Mass spectrometry-based proteomics provides a powerful tool for identifying sensitive and specific CRC biomarkers.
• This technology supports the shift towards personalized medicine in CRC management.